123 related articles for article (PubMed ID: 1693435)
1. Antibody-targeted photolysis: in vitro studies with Sn(IV) chlorin e6 covalently bound to monoclonal antibodies using a modified dextran carrier.
Rakestraw SL; Tompkins RG; Yarmush ML
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4217-21. PubMed ID: 1693435
[TBL] [Abstract][Full Text] [Related]
2. Antibody-targeted photolysis: in vitro immunological, photophysical, and cytotoxic properties of monoclonal antibody-dextran-Sn(IV) chlorin e6 immunoconjugates.
Rakestraw SL; Ford WE; Tompkins RG; Rodgers MA; Thorpe WP; Yarmush ML
Biotechnol Prog; 1992; 8(1):30-9. PubMed ID: 1371392
[TBL] [Abstract][Full Text] [Related]
3. Antibody-targeted photolysis. Bacteriocidal effects of Sn (IV) chlorin e6-dextran-monoclonal antibody conjugates.
Friedberg JS; Tompkins RG; Rakestraw SL; Warren SW; Fischman AJ; Yarmush ML
Ann N Y Acad Sci; 1991; 618():383-93. PubMed ID: 1706578
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of immunoconjugates for antibody-targeted photolysis.
Rakestraw SL; Tompkins RG; Yarmush ML
Bioconjug Chem; 1990; 1(3):212-21. PubMed ID: 1710935
[TBL] [Abstract][Full Text] [Related]
5. Sn-chlorin e6 antibacterial immunoconjugates. An in vitro and in vivo analysis.
Lu XM; Fischman AJ; Stevens E; Lee TT; Strong L; Tompkins RG; Yarmush ML
J Immunol Methods; 1992 Nov; 156(1):85-99. PubMed ID: 1431166
[TBL] [Abstract][Full Text] [Related]
6. Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates.
Oseroff AR; Ohuoha D; Hasan T; Bommer JC; Yarmush ML
Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8744-8. PubMed ID: 2877461
[TBL] [Abstract][Full Text] [Related]
7. Antibody-targeted photolysis of bacteria in vivo.
Berthiaume F; Reiken SR; Toner M; Tompkins RG; Yarmush ML
Biotechnology (N Y); 1994 Jul; 12(7):703-6. PubMed ID: 7764916
[TBL] [Abstract][Full Text] [Related]
8. Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial.
Oratz R; Speyer JL; Wernz JC; Hochster H; Meyers M; Mischak R; Spitler LE
J Biol Response Mod; 1990 Aug; 9(4):345-54. PubMed ID: 2395000
[TBL] [Abstract][Full Text] [Related]
9. Photocytotoxic action of EGF-PVA-Sn(IV)chlorin e6 and EGF-dextran-Sn(IV)chlorin e6 internalizable conjugates on A431 cells.
Gijsens A; De Witte P
Int J Oncol; 1998 Dec; 13(6):1171-7. PubMed ID: 9824627
[TBL] [Abstract][Full Text] [Related]
10. Control of hypertrophic scar growth using antibody-targeted photolysis.
Wolfort SF; Reiken SR; Berthiaume F; Tompkins RG; Yarmush ML
J Surg Res; 1996 Apr; 62(1):17-22. PubMed ID: 8606503
[TBL] [Abstract][Full Text] [Related]
11. Photoimmunotherapy of human ovarian carcinoma cells ex vivo.
Goff BA; Bamberg M; Hasan T
Cancer Res; 1991 Sep; 51(18):4762-7. PubMed ID: 1716512
[TBL] [Abstract][Full Text] [Related]
12. Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysis.
Oseroff AR; Ara G; Ohuoha D; Aprille J; Bommer JC; Yarmush ML; Foley J; Cincotta L
Photochem Photobiol; 1987 Jul; 46(1):83-96. PubMed ID: 3615636
[TBL] [Abstract][Full Text] [Related]
13. Photodestruction in vitro of tumour cells sensitized by porphyrins and their conjugates with specific antibodies.
Papkovskii DB; Savitskii AP; Egorova SG; Sukhin GM; Chissov VI; Krasnovskii AA; Egorov SYu ; Ponomarev GV; Kirillova GV
Biomed Sci; 1990 Apr; 1(4):401-6. PubMed ID: 2133059
[TBL] [Abstract][Full Text] [Related]
14. Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.
Del Governatore M; Hamblin MR; Piccinini EE; Ugolini G; Hasan T
Br J Cancer; 2000 Jan; 82(1):56-64. PubMed ID: 10638967
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates.
Kralovec J; Singh M; Mammen M; Blair AH; Ghose T
Cancer Immunol Immunother; 1989; 29(4):293-302. PubMed ID: 2787696
[TBL] [Abstract][Full Text] [Related]
16. Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations.
Rodwell JD; Alvarez VL; Lee C; Lopes AD; Goers JW; King HD; Powsner HJ; McKearn TJ
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2632-6. PubMed ID: 3458222
[TBL] [Abstract][Full Text] [Related]
17. Effects of methotrexate-carcinoembryonic-antigen-antibody immunoconjugates on GW-39 human tumors in nude mice.
Shih LB; Goldenberg DM
Cancer Immunol Immunother; 1990; 31(4):197-201. PubMed ID: 1696173
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin conjugated with a monoclonal antibody directed to a human melanoma-associated proteoglycan suppresses the growth of established tumor xenografts in nude mice.
Yang HM; Reisfeld RA
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1189-93. PubMed ID: 3422487
[TBL] [Abstract][Full Text] [Related]
19. Internalization of an intact doxorubicin immunoconjugate.
Shih LB; Goldenberg DM; Xuan H; Lu HW; Mattes MJ; Hall TC
Cancer Immunol Immunother; 1994 Feb; 38(2):92-8. PubMed ID: 8306371
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and selectivity of ricin toxin A chain-monoclonal antibody 791T/36 conjugates against human tumor cell lines.
Embleton MJ; Byers VS; Lee HM; Scannon P; Blackhall NW; Baldwin RW
Cancer Res; 1986 Nov; 46(11):5524-8. PubMed ID: 3489523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
